Iversen, Trine Zeeberg <br/><br/>
The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancer.  [electronic resource] 

 -  Basic & clinical pharmacology & toxicology  Jan 2015 
 - 19-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1742-7843 
<br/><br/><label>Standard No.: </label>10.1111/bcpt.12320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Dacarbazine--analogs & derivatives<br/>Humans<br/>Immunologic Factors<br/>Immunotherapy--methods<br/>Indoleamine-Pyrrole 2,3,-Dioxygenase--antagonists & inhibitors<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Interleukin-2--therapeutic use<br/>Ipilimumab<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Melanoma--drug therapy<br/>Prostatic Neoplasms--drug therapy<br/>Recombinant Proteins--therapeutic use<br/>Temozolomide<br/>Tissue Extracts--therapeutic use